Your browser doesn't support javascript.
loading
Effects of Complement Regulators and Chemokine Receptors in Type 2 Diabetes.
Aydin Ozgur, B; Coskunpinar, E; Bilgic Gazioglu, S; Yilmaz, A; Musteri Oltulu, Y; Cakmakoglu, B; Deniz, G; Gurol, A O; Yilmaz, M T.
Affiliation
  • Aydin Ozgur B; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Coskunpinar E; Department of Medical Biology and Genetics, Faculty of Medicine, Demiroglu Bilim University, Istanbul, Turkey.
  • Bilgic Gazioglu S; Department of Medical Biology, Faculty of Medicine, Health Science University, Istanbul, Turkey.
  • Yilmaz A; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Musteri Oltulu Y; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Cakmakoglu B; Department of Medical Biology, Faculty of Medicine, Biruni University, Istanbul, Turkey.
  • Deniz G; Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Gurol AO; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Yilmaz MT; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Immunol Invest ; 50(5): 478-491, 2021 Jul.
Article de En | MEDLINE | ID: mdl-32611246

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Antigènes CD59 / Antigènes CD55 / Récepteurs CXCR4 / Diabète de type 2 / Chimiokine CXCL12 / Génotype Type d'étude: Prognostic_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Immunol Invest Sujet du journal: ALERGIA E IMUNOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Turquie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Antigènes CD59 / Antigènes CD55 / Récepteurs CXCR4 / Diabète de type 2 / Chimiokine CXCL12 / Génotype Type d'étude: Prognostic_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Immunol Invest Sujet du journal: ALERGIA E IMUNOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Turquie